Femspas D 80mg/250mg Tablet
Marketer
Femgrace Formulations
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Femspas D 80mg/250mg Tablet
Abdominal pain relief is provided by the combined medication, Femspas D 80mg/250mg Tablet. This medication alleviates abdominal pain, bloating, discomfort, and cramping by relaxing the gastrointestinal tract's muscles and inhibiting pain-inducing chemical signals. Administered with food, the dosage and duration of Femspas D 80mg/250mg Tablet are determined by your physician, based on your individual response and condition. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Common, typically transient side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects immediately. Dizziness and drowsiness are potential side effects; avoid driving or activities requiring concentration until the medication's effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Pregnant or breastfeeding individuals, or those with liver or kidney issues, should disclose this information to their doctor prior to commencing treatment to ensure appropriate dosage.
Uses of Femspas D 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Femspas D 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Femspas D 80mg/250mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with a meal.
Common Side effects of Femspas D 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Femspas D 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without crushing, chewing, or breaking it. Consume Femspas D 80mg/250mg tablets with a meal.
How Femspas D 80mg/250mg Tablet works:
Femspas D 80mg/250mg tablets combine drotaverine and mefenamic acid to alleviate abdominal cramping and discomfort. Drotaverine, an antispasmodic, targets abdominal smooth muscle contractions, easing spasms. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory substances responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Combining Femspas D 80mg/250mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Femspas D 80mg/250mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Femspas D 80mg/250mg tablets with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Femspas D 80mg/250mg Tablets, a potential side effect of the medication due to the risk of dizziness.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Femspas D 80mg/250mg tablets; dosage modification may be necessary. Physician consultation is advised. Femspas D 80mg/250mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Femspas D 80mg/250mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Femspas D 80mg/250mg Tablet :
Should you forget a Femspas D 80mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Femspas D 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently